Target intelligence / Profile preview

OAZ1 pseudogene 1 (OAZ1P1)

Target
OAZ1P1
Molecular classification
Other
01

Overview

OAZ1 pseudogene 1 (OAZ1P1) is classified as a pseudogene and not a functional protein-coding gene or canonical molecule/receptor. Pseudogenes, by definition, resemble known genes but are typically non-functional due to mutations, lack of promoters, or inability to be translated into a functional protein. There is no evidence that OAZ1P1 serves as a receptor, enzyme, transporter, or therapeutic target. Canonical OAZ1 (Ornithine decarboxylase antizyme 1) is a well-characterized enzyme regulator involved in polyamine homeostasis and cell proliferation, but the pseudogene variant OAZ1P1 does not fulfill similar biological roles and is not recognized as a target in biomedical research or drug development[1][3][5]. If there is any confusion or misclassification regarding OAZ1P1 as a therapeutic target, it is due to its status as a pseudogene, which are generally not considered valid molecular targets. Note: The query seems to refer to OAZ1P1 as a molecular target, but current knowledge and database entries only recognize the functional OAZ1 gene/protein as a therapeutic or biological target. There is no strong evidence of OAZ1P1 encoding a protein, being involved in disease, serving as a biomarker, or interacting with drugs. This entry is thus marked as "is_incorrect: true" for the context of therapeutic targeting.

Other names
OAZ1P1OAZ1 pseudogenepotentially other similar pseudogene designations

Beyond the preview

Go deeper on OAZ1 pseudogene 1 (OAZ1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OAZ1 pseudogene 1 (OAZ1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call